On 29 January 2021, the Kemp Little team joined Deloitte Legal. Click here to view the press release.

As of 30 January 2021, Kemp Little LLP ceased to operate as a firm of solicitors and practice law and ceased to be regulated and authorised by the Solicitors Regulation Authority.

Kemp Little LLP has been re-named KL Heritage LLP.

If you are looking to contact a specific individual to seek legal advice or in respect of any other business relationship, please contact Deloitte Legal.

If you are seeking to contact the old Kemp Little LLP in relation to a previous business relationship or matter, please get in touch with KL Heritage LLP.

For enquiries relating to Kemp Little technology products and training portal, please email deloittelegal@deloitte.co.uk

 


 

Kemp Little is a trade name used under licence by KL Heritage LLP (formerly Kemp Little LLP, registered number OC300242 and VAT number 182 8854 65).

On 29 January 2021, the Kemp Little team joined Deloitte Legal.  As of 30 January 2021, Kemp Little ceased to operate as a firm of solicitors and practice law. From this date Kemp Little ceased to be authorised and regulated by the Solicitors Regulation Authority and is being re-named KL Heritage LLP.

All references to Kemp Little herein are references to KL Heritage LLP, which used to carry on business in that name.

KL Heritage LLP is not connected to or associated with Deloitte Legal or Deloitte LLP in any capacity.

 

Kemp Little
  • Looking for someone?
  • Email us
  • Search
MENU MENU
Insights overview

Commercial technology · 10 July 2019 · Alex Hazeldean

ASA rules influencers with over 30,000 followers are “celebrities”, subject to the CAP Code.

The Advertising Standards Authority (ASA) ruled on Wednesday that influencers with over 30,000 followers are “celebrities” and must adhere to the CAP Non-Broadcast Code, the… Read more

more content below

The Advertising Standards Authority (ASA) ruled on Wednesday that influencers with over 30,000 followers are “celebrities” and must adhere to the CAP Non-Broadcast Code, the rulebook which governs non-broadcast advertising, sales promotions and direct marketing in the UK when posting content.

The content in question was posted by Sarah Willox Knott on her Instagram account, @ThisMamaLife, in February 2019. The post featured a photo of Knott in bed smiling with a packet of Phenergan Night Time tablets on her bedside table. The caption of the post stated:

“[AD] Sleep. Who needs more of it? I’m really lucky in that I don’t actually need a lot of sleep to get by and manage to cram all sorts into my evening, being the night owl I am. Every now and again though, daily life can get a bit overwhelming and I often find it’s my sleep that ends up suffering. I end up going to bed even later than I usually do and am not able to fall asleep. The worry of not sleeping then adds to it all and I end up a complete and utter zombie!! Last time this happened I tried out Phenergan Night Time, which really helped. It is a pharmacy only, short term solution to insomnia for adults which works by inducing a sleepy effect thanks to its active ingredient, promethazine hydrochloride, helping you to sleep through the night. Do you guys fall asleep easily or are you night time over thinkers like me? #AD #sleep”

Rule 12.18 of the CAP Code states that marketers must not use health professionals or celebrities to endorse medicines. The ASA considered whether the ad used a celebrity to endorse a medicine, namely Phenergan Night Time.

Sanofi, the manufacturer of the medicine, responded that Knott’s Instagram account had a niche following and was therefore unlikely to influence medical decisions taken by consumers. Sanofi argued that Knott (who had 32,000 Instagram followers as of April 2019) could not be considered a celebrity when compared to other recognised celebrities such as David Beckham (55 million Instagram followers) and Stephen Fry (359,000 Instagram followers). Sanofi also referred the partnership with Knott to the Proprietary Association of Great Britain (the trade association for consumer healthcare in the UK) for approval prior to posting the ad.

The ASA noted that consumers would understand the caption of the ad to mean that Knott had used and recommended the product, concluding that Knott had endorsed the medicine.

Knott describes herself as a family blogger/vlogger and regularly produces content across different social media platforms relating to her experiences as a parent. Her Instagram feed features over 1,000 posts which include recommendations of various products.

Despite Sanofi’s arguments to the contrary, the ASA considered that Knott’s 30,000 followers meant she was popular with, and had the attention of, a large audience. As such, the ASA ruled that Knott was a celebrity for the purposes of the CAP Code, and she had endorsed a medicine, meaning the ad breached the Code.

The Ruling marks the first time an influencer has fallen foul of the ban on celebrity endorsements of medicines and comes after fellow influencer Sophie Hinchcliffe was investigated by the ASA in June for failing to identify sponsored posts on her Instagram account. Over the last few years, Instagram posts by many other influencers such as Louise Thompson, Millie Macintosh, and Marnie Simpson have also been subject to ASA action.

In practice, the effect of the Ruling is limited because most of the Code does not distinguish between celebrities and non-celebrities. Nevertheless, the Ruling highlights the need for brands, PR companies and influencers alike to pay close attention to the CAP Code before posting sponsored content on social media.

Despite the Ruling, influencers with fewer than 30,000 followers should not be considered to fall outside the scope of the Code due to any absence of ‘celebrity’ status – complaints relating to content posted on less popular accounts will still be considered by the ASA on a case-by-case basis.

Further reads: Social Media Hazards: protecting your brand in an influencers’ world

  • Share this blog

  • Twitter
  • Facebook
  • Linkedin

Alex HazeldeanAlex Hazeldean is a commercial technology associate

Get in touch

View the team

Sign up for our newsletters

  • Share this Blog

  • Twitter
  • Facebook
  • Linkedin

Other stuff you might like

  1. Are your offices ready for a post-lockdown return to work?
  2. Preparing for the New Normal | Webinar
  3. Retail reconsidered | KL Stores: a case study series exploring innovation in retail
The hottest topics in technology
  • Adtech & martech
  • Agile
  • Artificial intelligence
  • EBA outsourcing
  • Brexit
  • Cloud computing
  • Complex & sensitive investigations
  • Connectivity
  • Cryptocurrencies & blockchain
  • Cybersecurity
  • Data analytics & big data
  • Data breaches
  • Data rights
  • Digital commerce
  • Digital content risk
  • Digital health
  • Digital media
  • Digital infrastructure & telecoms
  • Emerging businesses
  • Financial services
  • Fintech
  • Gambling
  • GDPR
  • KLick DPO
  • KLick Trade Mark
  • Open banking
  • Retail
  • SMCR
  • Software & services
  • Sourcing
  • Travel
close
The hottest topics in technology
  • Adtech & martech
  • Agile
  • Artificial intelligence
  • EBA outsourcing
  • Brexit
  • Cloud computing
  • Complex & sensitive investigations
  • Connectivity
  • Cryptocurrencies & blockchain
  • Cybersecurity
  • Data analytics & big data
  • Data breaches
  • Data rights
  • Digital commerce
  • Digital content risk
  • Digital health
  • Digital media
  • Digital infrastructure & telecoms
  • Emerging businesses
  • Financial services
  • Fintech
  • Gambling
  • GDPR
  • KLick DPO
  • KLick Trade Mark
  • Open banking
  • Retail
  • SMCR
  • Software & services
  • Sourcing
  • Travel
Kemp Little

Lawyers
and thought leaders who are passionate about technology

Expand footer

Kemp Little

138 Cheapside
City of London
EC2V 6BJ

020 7600 8080

hello@kemplittle.com

Services

  • Commercial technology
  • Consulting
  • Disputes
  • Intellectual property
  • Employment
  • Immigration

 

  • Sourcing
  • Corporate
  • Data protection & privacy
  • Financial regulation
  • Private equity & venture capital
  • Tax

Sitemap

  • Our people
  • Insights
  • Events
  • About us
  • Contact us
  • Cookies
  • Privacy
  • Terms of use
  • Complaints
  • Debt recovery charges

Follow us

  • Twitter
  • LinkedIn
  • FlightDeck
  • Sign up for our newsletters

Kemp Little LLP is a limited liability partnership registered in England and Wales (registered number OC300242) and is authorised and regulated by the Solicitors Regulation Authority. Its registered office is 138 Cheapside, London EC2V 6BJ. The SRA Standards and Regulations can be accessed by clicking here.

  • Cyber Essentials logo
  • LORCA logo
  • ABTA Partner+ logo
  • Make Your Ask logo
  • FT Innovative Lawyers 2019 winners logo
  • Law Society Excellence Awards shortlisted
  • Legal Business Awards = highly commended
  • Home
  • Our people
  • Services
    • Business restructuring and reorganisation
    • Commercial technology
    • Consulting
    • Corporate
    • Data protection & privacy
    • Digital content & reputation risk
    • Disputes
    • Employment
    • Financial regulation
    • Immigration
    • Innovation
    • Intellectual property
    • Private equity & venture capital
    • Sourcing
    • Tax
    • Travel
  • Resources
  • Insights
  • Covid 19: Your Business Continuity
  • Events
  • About us
    • Who we are
    • Our social responsibilities
    • Our partnerships
    • Join us
  • Contact us
  • FlightDeck
  • Sign up for our newsletters
  • Follow us
    • Twitter
    • LinkedIn
close
close
close

Send us a message

Fill in your details and we'll be in touch soon

[contact-form-7 id="4941" title="General contact form"]
close

Sign up for our newsletter

I would like to receive updates and related news from Kemp Little *

Please select below any publications that you would like to receive:

Newsletters

close

Register for future event information

[contact-form-7 id="4943" title="Subscribe to future events"]
close
close
Generic filters
Exact matches only

Can't remember their name? View everyone

  • Home
  • Our people
  • Services
    • Business restructuring and reorganisation
    • Commercial technology
    • Consulting
    • Corporate
    • Data protection & privacy
    • Digital content & reputation risk
    • Disputes
    • Employment
    • Financial regulation
    • Immigration
    • Innovation
    • Intellectual property
    • Private equity & venture capital
    • Sourcing
    • Tax
    • Travel
  • Resources
  • Insights
  • Covid 19: Your Business Continuity
  • Events
  • About us
    • Who we are
    • Our social responsibilities
    • Our partnerships
    • Join us
  • Contact us
  • FlightDeck
  • Sign up for our newsletters
  • Follow us
    • Twitter
    • LinkedIn